• Recently, the U.S. Army selected L3Harris Technologies to supply its VAMPIRE counter‑drone systems under an order worth up to US$106 million, while the company also advanced plans for an IPO of its missile systems division, Axyv, following prior U.S. Department of Defense funding and ramped up VAMPIRE production in Huntsville, Alabama.
• These moves highlight how L3Harris is sharpening its focus on missile and counter‑drone technologies, aiming to align its portfolio more closely with evolving defense priorities and procurement needs.
• Next, we’ll examine how the Army’s VAMPIRE order and planned Axyv IPO could reshape L3Harris’s missile‑and‑space‑focused investment narrative.

The future of work is here. Discover the 31 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

L3Harris Technologies Investment Narrative Recap

To own L3Harris, you need to believe in sustained demand for advanced defense electronics, including missiles, space and counter drone systems, supported by healthy cash generation. The Army’s VAMPIRE award and the planned Axyv IPO both feed into that missile and c-UxS focus, but the near term story still hinges more on converting L3Harris’s large backlog into cash while managing fixed price development risks and potential U.S. budget pressures, particularly in space.

The most relevant recent announcement is the planned IPO of Axyv, the missile systems division, which follows a US$1 billion U.S. Department of Defense investment and is expected to raise up to US$2 billion. Together with the VAMPIRE order and missile production ramp in Huntsville, this move could reinforce L3Harris’s missile and space oriented investment narrative, but it also brings execution and contract risk into sharper focus as investors weigh the benefits of specialization against the complexity of fixed price work.

Yet investors should be aware that fixed price development contracts can compress margins if technical challenges or cost overruns start to...

L3Harris Technologies’ narrative projects $27.8 billion revenue and $3.0 billion earnings by 2029. This requires 7.3% yearly revenue growth and a $1.3 billion earnings increase from $1.7 billion today.

Uncover how L3Harris Technologies' forecasts yield a $381.95 fair value, a 30% upside to its current price.

Exploring Other Perspectives

Two Simply Wall St Community fair value estimates for L3Harris cluster between US$381.95 and US$405.75, underscoring how differently private investors can view the same cash flow outlook. Set against this spread, the company’s exposure to fixed price development contracts gives you a very specific risk to weigh as you consider which of these perspectives, if any, lines up with your expectations.

Explore 2 other fair value estimates on L3Harris Technologies - why the stock might be worth as much as 38% more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your L3Harris Technologies research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.
• Our free L3Harris Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate L3Harris Technologies' overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.
• We've uncovered the 8 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Outshine the giants: these 14 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.